Drug Trial Radar · NCT03906799
Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
Last checked: Nov 19, 2026Latest source record: Sep 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Mar 19, 2019
Primary completion
Nov 20, 2019
Study completion Mar 20, 2020
Sponsor
- Lead sponsor
- Omeicos Therapeutics GmbHIndustry
- Sponsor type
- Industry
- First posted
- Apr 8, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, dose-finding, placebo-controlled, parallel group, multicenter, phase II study to evaluate the efficacy, safety, and popPK of three different doses of OMT-28 given once daily versus placebo in patients with persistent AF.
Conditions
- Atrial Fibrillation
Interventions
OMT-28Drug
1 capsule given daily orally from Visit 3 (Day 1) to Visit 8 (Day 99 ± 3 days).
PlaceboDrug
1 capsule given daily orally from Visit 3 (Day 1) to Visit 8 (Day 99 ± 3 days).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of AF Burden After OMT-28 AdministrationTime frame: Up to 4.5 months
Locations
25 sites in 4 countries. Site status is shown where the registry gives one.
Site 401
Sofia, Bulgaria
Site 404
Stara Zagora, Bulgaria
Site 402
Varna, Bulgaria
Site 301
Kolín, Czechia
Site 303
Pilsen, Czechia
Site 302
Slaný, Czechia
Site 205
Budapest, Hungary
Site 201
Budapest, Hungary
Site 203
Debrecen, Hungary
Site 206
Hódmezővásárhely, Hungary
Site 202
Pécs, Hungary
Site 204
Zalaegerszeg, Hungary
Site 102
Cherkasy, Ukraine
Site 110
Ivano-Frankivsk, Ukraine
Site 104
Kharkiv, Ukraine
Site 107
Kharkiv, Ukraine
Site 108
Khmelnytskyi, Ukraine
Site 113
Kiev, Ukraine
Site 106
Kiev, Ukraine
Site 101
Kiev, Ukraine
Site 109
Kiev, Ukraine
Site 112
Kiev, Ukraine
Site 105
Odesa, Ukraine
Site 103
Uzhhorod, Ukraine
Site 111
Zhytomyr, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.